squamous-cell-carcinoma

Documents about squamous-cell-carcinoma

• FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors#148776ClinicalTrials.gov
• ASO Visual Abstract: Primary Breast Implant-Associated Squamous Cell Carcinoma: A Proposal for a Better Surgical Approach and Clinical Staging System Based on Tumor Characteristics#276285Repositório Institucional Unesp
• Elucidating IFI6 and RSAD2 protein expression in oral squamous cell carcinoma using immunohistochemistry and aptahistochemistry with novel in silico DNA-aptamers#298140USM Repository
• Performance of magnetic-resonance imaging radiomics in prediction of response after neoadjuvant chemotherapy in head and neck squamous cell carcinoma: A systematic review and meta-analysis.#330742NCBI PubMed Central
• A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell Carcinoma#343841ClinicalTrials.gov
• Morbus Bowen in the Os Pubis Region: Dermatosurgery as Treatment Choice#433370HAL (France)
• Supplemental Material for: Scrape Cytology of DEK::AFF2 Fusion-Associated Papillary Squamous Cell Carcinoma of the Sinonasal Tract Masquerading as Schneiderian Papilloma: A Case Report#436086Figshare
• Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL)#448283ClinicalTrials.gov
• Early and late mortality among patients with T1-T3 head and neck squamous cell carcinoma: a machine learning analysis using a SEER population-based cohort study.#645628NCBI PubMed Central
• Non-structural maintenance of chromosome condensin I complex subunit H knockdown suppresses malignant progression of esophageal squamous cell carcinoma via the Wnt/β-catenin signaling pathway.#666091NCBI PubMed Central
• Neoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCC#801961ClinicalTrials.gov
• Personalized Volume-deescalated Elective Nodal Irradiation in Oropharyngeal Head and Neck Squamous Cell Carcinoma#803144ClinicalTrials.gov
• Quantitative Assessment of Blood Supply in the Gastic Conduit With Fluorescence Angiography for Esophageal Reconstruction#827426ClinicalTrials.gov
• Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC#829118ClinicalTrials.gov
• Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.#867613ClinicalTrials.gov
• Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy#870602ClinicalTrials.gov
• Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC#894647ClinicalTrials.gov
• Lung Cancer Incidence Trends in South Africa from 2011 to 2022 and Investigation of Non- Small Cell Lung Cancer Biomarkers Using Rule-Based Natural Language Processing#447674WIReDSpace
• A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors#847545ClinicalTrials.gov
• Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors#899717ClinicalTrials.gov
• Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer#811979ClinicalTrials.gov
• Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery#839680ClinicalTrials.gov
• Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract#896549ClinicalTrials.gov
• A Study of NX-1607 in Adults With Advanced Malignancies#879199ClinicalTrials.gov
• Ezabenlimab and induction chemotherapy followed by adaptive chemoradiotherapy in patients with stage 3 squamous cell anal carcinoma (INTERACT-ION): an open-label, single-arm, phase 2 trial#322471HAL (France)
• Phase III Trial to Assess Efficacy and Safety of Cetuximab for the Treatment of Chinese Participants With Head and Neck Cancer#830146ClinicalTrials.gov
• SBRT With Cetuximab +/- Docetaxel Followed by Adjuvant Cetuximab +/- Docetaxel in Recurrent, Previously-Irradiated SCCHN#864406ClinicalTrials.gov
• Blood Biomarkers Based Screening for HPV-driven OPC#866362ClinicalTrials.gov
• Training Swallowing Initiation During Expiration#868869ClinicalTrials.gov
• Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer#896867ClinicalTrials.gov
• Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations#892861ClinicalTrials.gov
• A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours#870789ClinicalTrials.gov
• Clinical Research on the Effect of Aspirin on the Disease Free Survival Rate of Esophageal Carcinoma#891898ClinicalTrials.gov
• Reducing Excision Margins After Neoadjuvant Chemoimmunotherapy for HPV Negative Resectable Locally Advanced HNSCC#123475ClinicalTrials.gov
• Hypofractionated split-course versus standard radiotherapy in frail older patients with head and neck squamous-cell carcinoma (ELAN-RT trial): a non-inferiority, multicentre, open-label, randomised controlled trial#142628HAL (France)
• SBRT Followed by Chemoimmunotherapy of Toripalimab Plus Docetaxel and Cisplatin for Larynx Preservation in Patients with Locally Regionally Advanced Squamous Cell Carcinoma of the Larynx and Hypopharynx#249579ClinicalTrials.gov
• A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma#249594ClinicalTrials.gov
• A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors#272344ClinicalTrials.gov
• A novel antisense lncRNA, LPCRL, functions as a molecular scaffold for the USP15/MIB1 complex to promote primary cisplatin resistance and tumor progression in lung squamous cell carcinoma.#295261NCBI PubMed Central
• The Dutch cutaneous squamous cell carcinoma and metastasis (D-SQUAME) study: a nationwide discovery cohort and nationwide validation cohort with nested case-control designs for risk prediction modeling.#345212NCBI PubMed Central
• Preoperative Fibrinogen-to-Prealbumin Ratio and in-Hospital Postoperative Pneumonia After Minimally Invasive McKeown Esophagectomy for Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study with Infection Phenotype Profiling.#480840NCBI PubMed Central
• SPIO-enhanced MRI in Oral Cancer for Sentinel Lymph Node Identification#836962ClinicalTrials.gov
• Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma#845387ClinicalTrials.gov
• Cetuximab Plus Dalpicilib in Patients With HPV Negative, PD-1 Resistant R/M HNSCC#847552ClinicalTrials.gov
• Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer#869607ClinicalTrials.gov
• AMG 319 in HPV Positive and Negative HNSCC#880348ClinicalTrials.gov
• Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer#890880ClinicalTrials.gov
• Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy#898559ClinicalTrials.gov
• Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors#849329ClinicalTrials.gov
• Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix#855178ClinicalTrials.gov